Why Emergent BioSolutions Popped by Over 4% Today
It's always pleasant when one of our stocks pays us rather than the other way around. Such is the case with vaccine and antibody company Emergent BioSolutions (NYSE: EBS), which closed Friday more than 4% higher after it announced it would open its wallet to buy shares of its own equity.
Emergent BioSolutions is launching a fresh share-buyback program under which management is authorized to repurchase as much as $250 million worth of its common stock. This new initiative has a one-year duration ending on Nov. 11, 2022.
Image source: Getty Images.
Source Fool.com
